vs
Side-by-side financial comparison of Outdoor Holding Co (POWW) and Sunshine Biopharma Inc. (SBFM). Click either name above to swap in a different company.
Outdoor Holding Co is the larger business by last-quarter revenue ($13.4M vs $8.6M, roughly 1.6× Sunshine Biopharma Inc.). Outdoor Holding Co runs the higher net margin — 16.7% vs -25.0%, a 41.6% gap on every dollar of revenue. On growth, Sunshine Biopharma Inc. posted the faster year-over-year revenue change (-10.6% vs -54.1%). Outdoor Holding Co produced more free cash flow last quarter ($5.0M vs $-1.6M).
Vista Outdoor Inc. was an American designer, manufacturer, and marketer that operated in two segments: shooting sports and outdoor products. It was a "house of brands" with more than 40 labels and subsidiaries.
Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.
POWW vs SBFM — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.4M | $8.6M |
| Net Profit | $2.2M | $-2.1M |
| Gross Margin | 87.1% | 35.3% |
| Operating Margin | 14.7% | -20.9% |
| Net Margin | 16.7% | -25.0% |
| Revenue YoY | -54.1% | -10.6% |
| Net Profit YoY | 108.5% | 0.8% |
| EPS (diluted) | $0.01 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.4M | $8.6M | ||
| Q3 25 | $12.0M | $9.4M | ||
| Q2 25 | $11.9M | $9.4M | ||
| Q1 25 | $12.6M | $8.9M | ||
| Q4 24 | $12.5M | $9.6M | ||
| Q3 24 | $12.0M | $8.4M | ||
| Q2 24 | $12.3M | $9.3M | ||
| Q1 24 | $-50.7M | $7.5M |
| Q4 25 | $2.2M | $-2.1M | ||
| Q3 25 | $1.4M | $-883.8K | ||
| Q2 25 | $-6.5M | $-1.8M | ||
| Q1 25 | $-77.5M | $-1.2M | ||
| Q4 24 | $-26.1M | $-2.2M | ||
| Q3 24 | $-12.4M | $-1.2M | ||
| Q2 24 | $-14.8M | $-494.3K | ||
| Q1 24 | $-5.2M | $-1.3M |
| Q4 25 | 87.1% | 35.3% | ||
| Q3 25 | 87.1% | 32.6% | ||
| Q2 25 | 87.2% | 36.4% | ||
| Q1 25 | 87.5% | 30.7% | ||
| Q4 24 | 87.4% | 32.2% | ||
| Q3 24 | 86.9% | 34.0% | ||
| Q2 24 | 85.8% | 25.3% | ||
| Q1 24 | — | 31.2% |
| Q4 25 | 14.7% | -20.9% | ||
| Q3 25 | 5.9% | -11.5% | ||
| Q2 25 | -50.7% | -21.8% | ||
| Q1 25 | -213.6% | -14.6% | ||
| Q4 24 | -163.8% | -21.7% | ||
| Q3 24 | -50.3% | -13.1% | ||
| Q2 24 | -50.8% | -13.6% | ||
| Q1 24 | — | -17.9% |
| Q4 25 | 16.7% | -25.0% | ||
| Q3 25 | 11.7% | -9.4% | ||
| Q2 25 | -54.5% | -18.8% | ||
| Q1 25 | -614.5% | -13.3% | ||
| Q4 24 | -208.7% | -22.5% | ||
| Q3 24 | -103.7% | -14.2% | ||
| Q2 24 | -120.2% | -5.3% | ||
| Q1 24 | 10.3% | -17.0% |
| Q4 25 | $0.01 | — | ||
| Q3 25 | $0.01 | $-0.54 | ||
| Q2 25 | $-0.06 | $-0.82 | ||
| Q1 25 | $-0.67 | $-0.44 | ||
| Q4 24 | $-0.23 | $49.77 | ||
| Q3 24 | $-0.11 | $-11.61 | ||
| Q2 24 | $-0.13 | $-43.48 | ||
| Q1 24 | $-0.05 | $-2.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $69.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $237.3M | $23.0M |
| Total Assets | $271.7M | $30.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $69.9M | — | ||
| Q3 25 | $65.7M | — | ||
| Q2 25 | $63.4M | — | ||
| Q1 25 | $30.2M | — | ||
| Q4 24 | $31.9M | — | ||
| Q3 24 | $33.5M | — | ||
| Q2 24 | $50.8M | — | ||
| Q1 24 | $55.6M | — |
| Q4 25 | $237.3M | $23.0M | ||
| Q3 25 | $235.4M | $24.2M | ||
| Q2 25 | $222.5M | $25.7M | ||
| Q1 25 | $222.0M | $22.7M | ||
| Q4 24 | $299.6M | $23.5M | ||
| Q3 24 | $325.6M | $25.0M | ||
| Q2 24 | $342.5M | $23.5M | ||
| Q1 24 | $358.0M | $24.8M |
| Q4 25 | $271.7M | $30.1M | ||
| Q3 25 | $270.3M | $31.5M | ||
| Q2 25 | $269.5M | $32.0M | ||
| Q1 25 | $297.3M | $29.2M | ||
| Q4 24 | $355.4M | $30.6M | ||
| Q3 24 | $368.9M | $30.1M | ||
| Q2 24 | $398.6M | $29.3M | ||
| Q1 24 | $403.0M | $31.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.7M | $-1.6M |
| Free Cash FlowOCF − Capex | $5.0M | $-1.6M |
| FCF MarginFCF / Revenue | 37.6% | -18.9% |
| Capex IntensityCapex / Revenue | 4.8% | 0.0% |
| Cash ConversionOCF / Net Profit | 2.55× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-2.3M | $-5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.7M | $-1.6M | ||
| Q3 25 | $3.2M | $-727.8K | ||
| Q2 25 | $-6.7M | $-1.3M | ||
| Q1 25 | $-1.5M | $-1.7M | ||
| Q4 24 | $1.3M | $-3.4M | ||
| Q3 24 | $-9.3M | $-1.4M | ||
| Q2 24 | $-547.5K | $-4.6M | ||
| Q1 24 | $4.3M | $-3.2M |
| Q4 25 | $5.0M | $-1.6M | ||
| Q3 25 | $2.5M | $-735.8K | ||
| Q2 25 | $-7.6M | $-1.4M | ||
| Q1 25 | $-2.3M | $-1.7M | ||
| Q4 24 | $720.3K | $-3.5M | ||
| Q3 24 | $-10.6M | $-1.9M | ||
| Q2 24 | $-1.3M | $-5.6M | ||
| Q1 24 | $1.4M | $-3.2M |
| Q4 25 | 37.6% | -18.9% | ||
| Q3 25 | 21.0% | -7.8% | ||
| Q2 25 | -63.8% | -15.2% | ||
| Q1 25 | -18.6% | -19.3% | ||
| Q4 24 | 5.8% | -36.6% | ||
| Q3 24 | -88.3% | -22.2% | ||
| Q2 24 | -11.0% | -59.7% | ||
| Q1 24 | -2.8% | -43.1% |
| Q4 25 | 4.8% | 0.0% | ||
| Q3 25 | 5.8% | 0.1% | ||
| Q2 25 | 7.5% | 1.7% | ||
| Q1 25 | 6.5% | 0.1% | ||
| Q4 24 | 4.4% | 1.1% | ||
| Q3 24 | 10.4% | 6.1% | ||
| Q2 24 | 6.5% | 10.5% | ||
| Q1 24 | -5.7% | 0.8% |
| Q4 25 | 2.55× | — | ||
| Q3 25 | 2.29× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
